Myeloid Therapeutics Appoints Sadettin Ozturk, Ph.D., as Chief Technology and Manufacturing Officer

Myeloid CEO Daniel Getts Named an Emerging Pharma Leader by Pharmaceutical Executive Magazine

Myeloid Therapeutics Appoints Leading Immunologist, Cell & Gene Therapy Expert Bruce McCreedy, Ph.D.